Literature DB >> 19288163

Risk stratification with attenuation corrected stress Tc-99m sestamibi SPECT myocardial perfusion imaging in the absence of ECG-gating due to arrhythmias.

Sarkis B Baghdasarian1, Gavin L Noble, Alan W Ahlberg, Deborah Katten, Gary V Heller.   

Abstract

BACKGROUND: Despite growing recognition of attenuation correction (AC) utilizing an external radiation source, prognostic studies using AC are lacking.
METHODS: Consecutive patients (n = 419) who underwent stress Tc-99m sestamibi SPECT imaging with AC but without ECG-gating, due to arrhythmia, were followed for cardiac death or non-fatal myocardial infarction (MI). A 17-segment model and the summed stress score (SSS) were used to classify both the non-AC and AC images.
RESULTS: The 419 patients had a mean age of 71.5 +/- 11.7 years and most (70.6%) underwent pharmacologic stress. In follow-up, 35 (8.4%) patients suffered an adverse cardiac event. Patients with AC-SSS 1-3 and AC-SSS 4-8 had similar cardiac event rates (11.4% vs 10.5%, P = NS). Accordingly, AC-SSS cutoffs of 0, 1-8, and >8 were selected to classify perfusion as normal, mildly abnormal, and moderately to severely abnormal with annualized event rates of 2.1%, 10.8%, and 18.7%, respectively (P < .001). In multivariable analysis, AC-SSS >8 was the most powerful predictor of cardiac events followed by AC-SSS 1-8, history of CAD, age >75 and pharmacologic stress.
CONCLUSIONS: AC provides powerful risk stratification when added to clinical variables in patients undergoing stress Tc-99m sestamibi SPECT imaging without ECG-gating. Moreover, smaller/less severe defects on AC data are more significant than if the same defects were seen on non-AC data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288163     DOI: 10.1007/s12350-009-9071-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  30 in total

1.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

2.  Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities.

Authors:  H J Gallowitsch; J Sykora; P Mikosch; E Kresnik; O Unterweger; M Molnar; G Grimm; P Lind
Journal:  Eur J Nucl Med       Date:  1998-03

3.  Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation.

Authors:  Yasmin Masood; Yi-Hwa Liu; Gordon Depuey; Raymond Taillefer; Luis I Araujo; Steven Allen; Dominique Delbeke; Frank Anstett; Aharon Peretz; Mary-Jo Zito; Vera Tsatkin; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

4.  Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi.

Authors:  N Nallamouthu; L Araujo; J Russell; J Heo; A E Iskandrian
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

5.  Initial experience with X-ray CT based attenuation correction in myocardial perfusion SPECT imaging using a combined SPECT/CT system.

Authors:  Daisuke Utsunomiya; Seiji Tomiguchi; Shinya Shiraishi; Koichiro Yamada; Tsuyoshi Honda; Koichi Kawanaka; Akihiro Kojima; Kazuo Awai; Yasuyuki Yamashita
Journal:  Ann Nucl Med       Date:  2005-09       Impact factor: 2.668

6.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

7.  Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia.

Authors:  R Hachamovitch; D S Berman; H Kiat; I Cohen; H Lewin; A Amanullah; X Kang; J Friedman; G A Diamond
Journal:  Am J Cardiol       Date:  1997-08-15       Impact factor: 2.778

8.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

9.  Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.

Authors:  G V Heller; S D Herman; M I Travin; J I Baron; C Santos-Ocampo; J R McClellan
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

10.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

View more
  15 in total

1.  Attenuation corrected myocardial perfusion SPECT provides powerful risk stratification in patients with coronary artery disease.

Authors:  Ernest V Garcia; Fabio P Esteves
Journal:  J Nucl Cardiol       Date:  2009-04-03       Impact factor: 5.952

2.  Nuclear cardiology in the present and beyond: can we meet the challenges?

Authors:  Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-05-25       Impact factor: 5.952

3.  Stress-only myocardial perfusion imaging … it is time for a change!

Authors:  Sanjeev P Bhavnani; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

4.  Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging.

Authors:  Afrooz Ardestani; Alan W Ahlberg; Deborah M Katten; Krista Santilli; Donna M Polk; Timothy M Bateman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-11-21       Impact factor: 5.952

5.  Fully automated analysis of attenuation-corrected SPECT for the long-term prediction of acute myocardial infarction.

Authors:  Manish Motwani; William D Leslie; Andrew L Goertzen; Yuka Otaki; Guido Germano; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2017-03-13       Impact factor: 5.952

6.  CT-based attenuation correction in Tl-201 myocardial perfusion scintigraphy is less effective than non-corrected SPECT for risk stratification.

Authors:  Christos A Savvopoulos; Trifon Spyridonidis; Nikolaos Papandrianos; Pavlos J Vassilakos; Dimitrios Alexopoulos; Dimitris J Apostolopoulos
Journal:  J Nucl Cardiol       Date:  2014-02-15       Impact factor: 5.952

7.  Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort.

Authors:  Marisa C G Tjong Joe Wai; Machiel J M Ottenhof; Hendrik J Boiten; Roelf Valkema; Ron T van Domburg; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952

8.  Clinical value of stress-only Tc-99m SPECT imaging: importance of attenuation correction.

Authors:  Shishir Mathur; Gary V Heller; Timothy M Bateman; Richard Ruffin; Arshad Yekta; Deborah Katten; Nitya Alluri; Alan W Ahlberg
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

9.  15-Year outcome after normal exercise ⁹⁹mTc-sestamibi myocardial perfusion imaging: what is the duration of low risk after a normal scan?

Authors:  Arend F L Schinkel; Henk J Boiten; Jors N van der Sijde; Pauline R Ruitinga; Eric J G Sijbrands; Roelf Valkema; Ron T van Domburg
Journal:  J Nucl Cardiol       Date:  2012-06-08       Impact factor: 5.952

10.  Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.

Authors:  Hendrik J Boiten; Johannes N van der Sijde; Pauline R Ruitinga; Roelf Valkema; Marcel L Geleijnse; Eric J G Sijbrands; Ron T van Domburg; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2012-08-09       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.